Amgen, Inc. (AMGN) Tops Q2 EPS by 30c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Amgen (AMGN) PT Raised to $135 at BMO Capital
July 30, 2014 9:11 AM EDTBMO Capital analyst Jim Birchenough reiterated a Market Perform rating and bumped his price target on Amgen (NASDAQ: AMGN) to $135.00 (from $125.00) following Q2 results
Birchenough comments, "While AMGN continues to execute well on generating a return from legacy products, we believe that transformational growth... More
Amgen (AMGN) PT, Estimates Raised at Piper Jaffray Following 'Robust' Q2
July 30, 2014 9:07 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Amgen (NASDAQ: AMGN) to $150.00 (from $143.00) following "robust" Q2 results after the close.
Schimmer comments, "AMGN reported a robust 2Q after the close, with total revenue of $5.18B... More
